- Home
- IVDA vs PRFX Comparison
IVDA vs PRFX Comparison
Compare IVDA & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | PRFX |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | Israel |
| Employees | 32 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 2.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IVDA | PRFX |
|---|---|---|
| Price | $0.28 | $2.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 863.5K | 31.2K |
| Earning Date | 04-14-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $340.48 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.58 |
| 52 Week High | $3.13 | $3.71 |
Technical Indicators
Market Signals| Indicator | IVDA | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 44.70 |
| Support Level | $0.27 | $1.28 |
| Resistance Level | $0.34 | $2.95 |
| Average True Range (ATR) | 0.04 | 0.22 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 7.25 | 10.00 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.